Suchergebnisse - Hirva Mamdani

  • Treffer 1 - 9 von 9
Treffer weiter einschränken
  1. 1
    Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?

    Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope? von Hirva Mamdani, Shadia I. Jalal

    Veröffentlicht 2020
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Blood-based tumor biomarkers in lung cancer for detection and treatment

    Blood-based tumor biomarkers in lung cancer for detection and treatment von Hirva Mamdani, Shahid Ahmed, Samantha Armstrong, Tony Mok, Shadia I. Jalal

    Veröffentlicht 2017
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Immunotherapy in Lung Cancer: Current Landscape and Future Directions

    Immunotherapy in Lung Cancer: Current Landscape and Future Directions von Hirva Mamdani, Sandro Matosevic, Ahmed Bilal Khalid, Gregory A. Durm, Shadia I. Jalal

    Veröffentlicht 2022
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies

    Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies von Melissa L. Johnson, Anthony B. El-Khoueiry, Navid Hafez, Nehal J. Lakhani, Hirva Mamdani, Jordi Rodón, Rachel E. Sanborn, Javier Garciá Corbacho, Valentina Boni, Mark Stroh, Alison L. Hannah, Song Wang, Henry Castro, Alexander I. Spira

    Veröffentlicht 2021
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)

    Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4) von Robin Cornelissen, Arsela Prelaj, Sophie Sun, Christina S. Baik, Mirjana Wollner, Eric B. Haura, Hirva Mamdani, Jonathan W. Riess, Federico Cappuzzo, Marina Chiara Garassino, John V. Heymach, Mark A. Socinski, Szu‐Yun Leu, Gajanan Bhat, François Lebel, Xiuning Le

    Veröffentlicht 2023
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial

    Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial von Jeffrey Clarke, George R. Simon, Hirva Mamdani, Lin Gu, James E. Herndon, Thomas E. Stinchcombe, Neal Ready, Jeffrey Crawford, Guru Sonpavde, Stephen J. Balevic, Andrew B. Nixon, Michael J. Campa, Elizabeth B. Gottlin, Huihua Li, Ruchi Saxena, You‐Wen He, Scott Antonia, Edward F. Patz

    Veröffentlicht 2025
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

    Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer von Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M. Vanderwalde, Hirva Mamdani, Luis E. Raez, Misako Nagasaka, Sachin Gopalkrishna Pai, Mark A. Socinski, Jorge J. Nieva, Chul Kim, Antoinette J. Wozniak, Chukwuemeka Ikpeazu, Gilberto Lopes, Alexander I. Spira, W. Michael Korn, Edward S. Kim, Stephen V. Liu, Hossein Borghaei

    Veröffentlicht 2021
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

    Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline von Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi

    Veröffentlicht 2022
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

    Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline von Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi

    Veröffentlicht 2022
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: